On the other hand, heart-specific overexpression of ANT1 has distinctive cardioprotective effects in various experimental heart diseases, such as hypertension-induced hypertrophic cardiomyopathy, as well as diabetic or ischemic heart disease [8,9,10]. Here, SLC25A4 is linked to heart disorder.